Acne clinical trials

Explore recruiting acne clinical trials.

Recruiting acne studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Acne trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Double-blind, randomised clinical study comparing efficacy and safety of Clindamycin/Tretinoin Gel (10 mg/g + 0.25 mg/g) (Test) vs. Acnatac(R) 10 mg/g + 0.25 mg/g Gel (Reference) vs. Vehicle in patients with papulopustular acne

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase 2 randomized, double blind, placebo-controlled study to evaluate the safety and efficacy of topical AT-004 1% in the participants with acne vulgaris.

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-1)

Spain, Italy, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-2)

Italy, Spain, Poland

Therapeutic confirmatory (Phase III) EU CTIS Study details

Optimizing metformin use in polycystic ovary syndrome - A randomized controlled trial

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Acne trials by city

Acne in Toronto Acne in Vancouver Acne in Montreal Acne in Calgary Acne in Edmonton Acne in Ottawa Acne in Winnipeg Acne in Quebec City Acne in Hamilton Acne in Kitchener Acne in London Acne in Halifax Acne in New York Acne in Los Angeles Acne in Chicago Acne in Houston

Acne clinical trials

Recruiting acne studies right now

Impact of Rifampicin in Treatment Outcome of Cutibacterium Acnes Prosthetic Joint Infections

Efficacy and Safety of Adapalene Gel and Hyaluronic Acid Versus Adapalene Gel Alone in Mild to Moderate Acne Vulgaris

Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Participants With Mild Acne

Evaluation of Juläine (TM) for the Treatment of Atrophic Facial Acne Scars

Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients

Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne

The Use of Image-Based Computer Gradings in the Analysis of Acne, Rosacea, Melasma, and Seborrheic Dermatitis

Efficacy and Tolerability of the Tested Formula After 3 Months in Treatment of Facial Hyperpigmentation of 3 Origins

Efficacy of 0.5% Topical Timolol Eye Drops in the Treatment of Post-Inflammatory Erythema Following Acne Vulgaris

A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars

Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery

Also recruiting in Europe

Randomized clinical trial to compare oral isotretinoin to standard of care in moderate acne skin of color patients

Double-blind, randomised clinical study comparing efficacy and safety of Clindamycin/Tretinoin Gel (10 mg/g + 0.25 mg/g) (Test) vs. Acnatac(R) 10 mg/g + 0.25 mg/g Gel (Reference) vs. Vehicle in patients with papulopustular acne

A phase 2 randomized, double blind, placebo-controlled study to evaluate the safety and efficacy of topical AT-004 1% in the participants with acne vulgaris.

A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-1)

A phase III study to assess efficacy and safety of N-Acetyl-GED-0507-34-LEVO gel 5%, applied once daily for 12 weeks in patients with acne vulgaris (GEDACNE-2)

Optimizing metformin use in polycystic ovary syndrome - A randomized controlled trial

Acne trials by city

Other conditions